104 related articles for article (PubMed ID: 25442919)
1. Comparative effects of hypoxia and hypoxia mimetic cobalt chloride on in vitro adhesion, biofilm formation and susceptibility to amphotericin B of Candida glabrata.
Gupta P; Nath S; Meena RC; Kumar N
J Mycol Med; 2014 Dec; 24(4):e169-77. PubMed ID: 25442919
[TBL] [Abstract][Full Text] [Related]
2. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
[TBL] [Abstract][Full Text] [Related]
3. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.
Kucharíková S; Neirinck B; Sharma N; Vleugels J; Lagrou K; Van Dijck P
J Antimicrob Chemother; 2015 Mar; 70(3):846-56. PubMed ID: 25406296
[TBL] [Abstract][Full Text] [Related]
4. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
Samaranayake YH; Yau JY; Thein ZM; Jayatilake JA; Yeung KW; Samaranayake LP
Med Mycol; 2010 Aug; 48(5):725-34. PubMed ID: 20092419
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation.
Prażyńska M; Gospodarek E
Mycopathologia; 2014 Feb; 177(1-2):19-27. PubMed ID: 24436013
[TBL] [Abstract][Full Text] [Related]
6. Candida glabrata's recurrent infections: biofilm formation during Amphotericin B treatment.
Rodrigues CF; Silva S; Azeredo J; Henriques M
Lett Appl Microbiol; 2016 Aug; 63(2):77-81. PubMed ID: 27259377
[TBL] [Abstract][Full Text] [Related]
7. Growth, biofilm formation, antifungal susceptibility and oxidative stress resistance of Candida glabrata are affected by different glucose concentrations.
Ng TS; Desa MNM; Sandai D; Chong PP; Than LTL
Infect Genet Evol; 2016 Jun; 40():331-338. PubMed ID: 26358577
[TBL] [Abstract][Full Text] [Related]
8. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
9. Lab-scale preparations of Candida albicans and dual Candida albicans-Candida glabrata biofilms on the surface of medical-grade polyvinyl chloride (PVC) perfusion tube using a modified gravity-supported free-flow biofilm incubator (GS-FFBI).
Shao J; Lu K; Tian G; Cui Y; Yan Y; Wang T; Zhang X; Wang C
J Microbiol Methods; 2015 Feb; 109():41-8. PubMed ID: 25528294
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of Candida glabrata ORF, CAGL0M02233g for its role in stress tolerance and virulence.
Gupta P; Meena RC; Kumar N
Microb Pathog; 2020 Dec; 149():104469. PubMed ID: 32890635
[TBL] [Abstract][Full Text] [Related]
11. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
12. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
[TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
15. Bioactivity and cellular structure of Candida albicans and Candida glabrata biofilms grown in the presence of fluconazole.
Gomes PN; da Silva WJ; Pousa CC; Narvaes EA; Del Bel Cury AA
Arch Oral Biol; 2011 Nov; 56(11):1274-81. PubMed ID: 21549350
[TBL] [Abstract][Full Text] [Related]
16. Proteomics of drug resistance in Candida glabrata biofilms.
Seneviratne CJ; Wang Y; Jin L; Abiko Y; Samaranayake LP
Proteomics; 2010 Apr; 10(7):1444-54. PubMed ID: 20127690
[TBL] [Abstract][Full Text] [Related]
17. The multidrug resistance transporters CgTpo1_1 and CgTpo1_2 play a role in virulence and biofilm formation in the human pathogen Candida glabrata.
Santos R; Costa C; Mil-Homens D; Romão D; de Carvalho CC; Pais P; Mira NP; Fialho AM; Teixeira MC
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27780306
[TBL] [Abstract][Full Text] [Related]
18. Antifungal and anti-biofilm activity of a new Spanish extract of propolis against Candida glabrata.
Fernández-Calderón MC; Hernández-González L; Gómez-Navia C; Blanco-Blanco MT; Sánchez-Silos R; Lucio L; Pérez-Giraldo C
BMC Complement Med Ther; 2021 May; 21(1):147. PubMed ID: 34020643
[TBL] [Abstract][Full Text] [Related]
19. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms.
Seneviratne CJ; Silva WJ; Jin LJ; Samaranayake YH; Samaranayake LP
Arch Oral Biol; 2009 Nov; 54(11):1052-60. PubMed ID: 19712926
[TBL] [Abstract][Full Text] [Related]
20. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
